The Use of Agents that By–Pass Factor VIII Inhibitors in Patients with Haemophilia

The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIII

1981 • 303 citations

Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIII

1980 • 257 citations

Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.

1998 • 244 citations

Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII

1983 • 125 citations

Platelet procoagulant complex assembly in a tissue factor‐initiated system

1994 • 112 citations

The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleedings in patients with haemophilia A with an inhibitor to Factor VIII

1982 • 90 citations

Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors

1976 • 53 citations

Antihemophilic factor inhibitors. Management with prothrombin complex concentrates

1976 • 53 citations

Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor

1992 • 29 citations

Measurement of active coagulation factors in Autoplex-T with colorimetric active site-specific assay technology.

1998 • 19 citations

Magnetic resonance imaging of myocardial infarction during prothrombin complex concentrate therapy of hemophilia A

1997 • 17 citations

Treatment of Acute Bleeding Episodes with rFVIIa

1999 • 13 citations